OasisLMS

Upon completion of this activity, participants should be able to:

• Explain imposter syndrome and microaggressions
• Discuss how both imposter syndrome and microaggressions affect confidence, performance and mental well-being in professional settings
• Provide actionable techniques to manage self-doubt, reframe negative thoughts and build confidence

This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Continuing Medical Education Committee. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education. The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings

Anu Nookala, MD
Scientific Consultant/Advisor: Gilead, Ipsen
Speakers Bureau: Gilead, Intercept

Nicole Loo, MD
Scientific Consultant/Advisor: Ipsen

Dawn Sears, MD

Elizabeth Verna, MD, MS, FAASLD
Research Grant: Salix

Michelle Kim, MD

Tatyana Kushner, MD, MSCE
Research Grants: Icahn School of Medicine, Gilead
Scientific Consultant/Advisor: Gilead, HDV, Eiger, AbbVie, GlaxoSmithKline, Madrigal, Ipsen, Mirum, VIR, Bluejay

Dr. Dawn Sears is a highly regarded gastroenterologist and clinical professor at UT Southwestern Medical Center. She has extensive experience in the field, having graduated from Texas A&M University College of Medicine in 1998. Dr. Sears has been in practice for over 20 years and is board certified in gastroenterology and hepatology. She is known for her leadership roles in gastroenterology and her efforts to empower women physicians. Dr. Sears is also an executive coach for women in medicine, focusing on reducing burnout and promoting mentorship and support among female physicians. Her work has been recognized with numerous awards and accolades, reflecting her dedication to advancing the field of gastroenterology and supporting the next generation of healthcare professionals.

Dr. Betsy Verna is a transplant hepatologist, clinical researcher, and educator at Columbia University. She is the Director of Clinical Research for Columbia’s Transplant Clinical Research Center, responsible for the development and execution of clinical trials and research across solid organ transplantation. Dr. Verna has made substantial contributions to transplantation, including the development of HCV treatment guidelines and research on the impact of the intestinal microbiome on liver transplant outcomes. She has coauthored over 60 original publications and serves as an Associate Editor for the journal Liver Transplantation. Dr. Verna has been involved in various leadership roles within the American Society of Transplantation and the Liver Intestine Community of Practice. She was recognized for her contributions to transplantation in 2017 with the AST Clinical Science Career Development Award and named a Fellow of the AST.

Dr. Michelle Kim is an internationally recognized gastroenterologist and physician scientist who serves as Chair of the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, where she leads one of the nation’s most respected digestive disease programs. Widely regarded as a leading expert in neuroendocrine tumors and gastrointestinal cancers, Dr. Kim has built her career at the intersection of clinical excellence, research innovation, and health equity. Before joining the Cleveland Clinic, she spent nearly two decades at the Icahn School of Medicine at Mount Sinai, rising to Professor of Medicine and serving as Vice Chair for Faculty Affairs in the Department of Medicine, as well as Co Director of the Center for Carcinoid and Neuroendocrine Tumors. Her research portfolio spans translational science, epidemiology, and disparities in cancer care, and she has authored more than 80 peer reviewed publications in high impact journals. Dr. Kim is also deeply engaged in national leadership, serving as President of the Korean American Medical Association and Chair of the Carcinoid and Neuroendocrine Tumor Section of the American Gastroenterological Association. A graduate of Harvard University, she earned her medical degree from Stanford University School of Medicine and completed her residency and fellowship training at NewYork Presbyterian/Weill Cornell. Known for her compassionate approach to patient care and her commitment to mentoring the next generation of physicians—particularly women and underrepresented minorities—Dr. Kim continues to shape the field of gastroenterology through her clinical work, scholarship, and advocacy.

https://www.aasld.org/terms-use-and-privacy-policy